argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
02 mar 2021 - 08:00
Statutory name
argenx SE
Title
argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis
Date last update: 04 November 2026